Researcher
Karen Van Baelen
- Disciplines:Genetics, Transcription and translation, Molecular and cell biology not elsewhere classified, Cancer biology
Affiliations
- Laboratory for Translational Breast Cancer Research (Division)
Member
From1 Aug 2020 → Today
Projects
1 - 1 of 1
- Clinical, pathological and molecular characterization of invasive lobular carcinoma (ILC)From12 Aug 2020 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
Publications
1 - 10 of 22
- Reporting on invasive lobular breast cancer in clinical trials: a systematic review.(2024)
Authors: Karen Van Baelen, Josephine Van Cauwenberge, Beppe Floris, Patrick Neven, Hans Wildiers, Christine Desmedt
Pages: 23 - Histopathological growth patterns and tumor-infiltrating lymphocytes in breast cancer liver metastases(2023)
Authors: Sophia Leduc, Maxim De Schepper, François Richard, Anirudh Pabba, Kristien Borremans, Gitte Zels, Karen Van Baelen, Ha Linh Nguyen, Tatjana Geukens, Baki Topal, et al.
- Association of body mass index with clinicopathological features and survival in patients with primary invasive lobular breast cancer(2023)
Authors: Karen Van Baelen, Ha Linh Nguyen, François Richard, Maxim De Schepper, Tatjana Geukens, Sileny Han, Thaïs Baert, Hans Wildiers, Ann Smeets, Ines Nevelsteen, et al.
- Obesity-associated changes in molecular biology of primary breast cancer(2023)
Authors: Ha Linh Nguyen, Tatjana Geukens, Maxim De Schepper, Stefan Naulaerts, Ines Nevelsteen, Patrick Neven, Karen Van Baelen, Hanne Vos, Hans Wildiers, Beppe Floris, et al.
- Intra-patient and inter-metastasis heterogeneity of HER2-low status in metastatic breast cancer(2023)
Authors: Tatjana Geukens, Maxim De Schepper, François Richard, Karen Van Baelen, Ha Linh Nguyen, Sophia Leduc, Anirudh Pabba, Gitte Zels, Ann Smeets, Ines Nevelsteen, et al.
Pages: 152 - 160 - Comparison of the genomic alterations present in tumor samples from patients with metastatic inflammatory versus non-inflammatory breast cancer reveals AURKA as a potential treatment target(2023)
Authors: François Richard, Maxim De Schepper, Sophia Leduc, Tatjana Geukens, Karen Van Baelen, Ha Linh Nguyen, Beppe Floris, Christine Desmedt
Pages: 476 - 480 - Can ADCs broaden the treatment landscape of metastatic ER+/HER2- breast cancer resistant to CDK4/6 inhibition?(2023)
Authors: Karen Van Baelen, Christine Desmedt, Hans Wildiers, Patrick Neven
Pages: 269 - Association of body mass index with clinicopathological features and survival in patients with primary ER+/HER2-invasive lobular breast cancer(2023)
Authors: Karen Van Baelen, François Richard, Maxim De Schepper, Tatjana Geukens, Hans Wildiers, Ines Nevelsteen, Beppe Floris, Patrick Neven, Christine Desmedt
- Transcriptomic insights into lobular breast cancer biology: a retrospective analysis of the MINDACT clinical trial(2023)
Authors: Christine Desmedt, François Richard, Karen Van Baelen
- Histopathological and immune characterization of liver metastases from patients with breast cancer(2023)
Authors: Maxim De Schepper, Beppe Floris, François Richard, Baki Topal, Karen Van Baelen, Tatjana Geukens, Ha Linh Nguyen, Christine Desmedt